Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lassen, JF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ravn, HB; Lassen, JF; Bergenhem, N; Kristensen, AT
      Intravenous magnesium does not influence the activity of the coagulation cascade

      BLOOD COAGULATION & FIBRINOLYSIS
    2. Kristensen, JK; Sandbaek, A; Lassen, JF; Bro, F; Lauritzen, T
      Use and validation of public data files for identification of the diabeticpopulation in a Danish county

      DANISH MEDICAL BULLETIN
    3. Botker, HE; Lassen, JF; Hermansen, F; Wiggers, H; Sogaard, P; Kim, WY; Bottcher, M; Thuesen, L; Pedersen, AK
      Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy

      CIRCULATION
    4. Kristiansen, C; Lassen, JF; Dahler-Eriksen, BS; Dahler-Eriksen, K; Larsen, TB; Brandslund, I
      Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulation

      THROMBOSIS RESEARCH
    5. Lauritzen, T; Mainz, J; Lassen, JF
      From science to everyday clinical practice. Need for systematic evaluationof research findings

      SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
    6. Dahler-Eriksen, BS; Lauritzen, T; Lassen, JF; Lund, ED; Brandslund, I
      Near-patient test for C-reactive protein in general practice: Assessment of clinical, organizational, and economic outcomes

      CLINICAL CHEMISTRY
    7. LARSEN TB; LASSEN JF; DAHLERERIKSEN BS; PETERSEN PH; BRANDSLUND I
      EFFECT OF ANTICOAGULANT-THERAPY ON THE HYPERCOAGULABLE STATE IN PATIENTS CARRYING THE FACTOR-V ARG506GLN MUTATION

      Thrombosis research
    8. LARSEN TB; LASSEN JF; BRANDSLUND I; BYRIEL L; PETERSEN GB; NORGAARDPEDERSEN B
      THE ARG506GLN MUTATION (FV LEIDEN) AMONG A COHORT OF 4188 UNSELECTED DANISH NEWBORNS

      Thrombosis research
    9. KJELDSEN J; LASSEN JF; BRANDSLUND I; DEMUCKADELL OBS
      MARKERS OF COAGULATION AND FIBRINOLYSIS AS MEASURES OF DISEASE-ACTIVITY IN INFLAMMATORY BOWEL-DISEASE

      Scandinavian journal of gastroenterology
    10. LARSEN TB; LASSEN JF; BRANDSLUND I
      ORAL ANTICOAGULANT-THERAPY (OAT) IS EFFECTIVE IN PATIENTS WITH APC-RESISTANCE (ARG506GLN OR FV-LEIDEN) EVIDENCED BY REDUCTION IN LEVELS OF PROTHROMBIN ACTIVATION FRAGMENT-1+2 IN PLASMA FROM A MATCHED GROUP OF PATIENTS

      Thrombosis and haemostasis
    11. RAVN HB; KRISTENSEN SD; LASSEN JF; HUSTED SE
      IMPACT OF INTRAVENOUS MAGNESIUM ON MARKERS OF COAGULATION

      Thrombosis and haemostasis
    12. BRANDSLUND I; DAHLERERIKSEN BS; LASSEN JF; DAHLERERIKSEN K; LARSEN TB
      CHANGE FROM PHENPROCOUMON TO WARFARIN - SCHEME AND PROGRAM FOR MONITORING AND DOSE-ADJUSTMENTS

      Thrombosis and haemostasis
    13. LASSEN JF; DAHLERERIKSEN BS; DAHLERERIKSEN K; LARSEN TB; HUSTED SE; BRANDSLUND I
      EFFECT OF CHANGE FROM PHENPROCOUMON TO WARFARIN ON MARKERS OF COAGULATION AND FIBRINOLYSIS

      Thrombosis and haemostasis
    14. DAHLERERIKSEN BS; LASSEN JF; LUND ED; LAURITZEN T; BRANDSLUND I
      C-REACTIVE PROTEIN IN GENERAL-PRACTICE - HOW COMMONLY IS IT USED AND WHY

      Scandinavian journal of primary health care
    15. PETERSEN PH; STOCKL D; BLAABJERG O; PEDERSEN B; BIRKEMOSE E; THIENPONT L; LASSEN JF; KJELDSEN J
      GRAPHICAL INTERPRETATION OF ANALYTICAL DATA FROM COMPARISON OF A FIELD METHOD WITH A REFERENCE METHOD BY USE OF DIFFERENCE PLOTS

      Clinical chemistry
    16. DAHLERERIKSEN BS; LASSEN JF; PETERSEN PH; LUND ED; LAURITZEN T; BRANDSLUND I
      EVALUATION OF A NEAR-PATIENT TEST FOR C-REACTIVE PROTEIN USED IN DAILY ROUTINE IN PRIMARY HEALTH-CARE BY USE OF DIFFERENCE PLOTS

      Clinical chemistry
    17. KJELDSEN J; LASSEN JF; PETERSEN PH; BRANDSLUND I
      BIOLOGICAL VARIATION OF INTERNATIONAL-NORMALIZED-RATIO FOR PROTHROMBIN TIMES, AND CONSEQUENCES IN MONITORING ORAL ANTICOAGULANT-THERAPY - COMPUTER-SIMULATION OF SERIAL MEASUREMENTS WITH GOAL-SETTING FOR ANALYTICAL QUALITY

      Clinical chemistry
    18. LASSEN JF
      ORAL ANTICOAGULANT-THERAPY - A QUALITY ASSESSMENT

      Danish medical bulletin
    19. LASSEN JF; LUND ED; KNUDSEN L; ERIKSEN B; BRANDSLUND I
      INTERPRETATION OF SERIAL MEASUREMENTS OF PROTHROMBIN FRAGMENT 1-THERAPY(2 IN ANTICOAGULANT)

      Thrombosis and haemostasis
    20. LASSEN JF; BRANDSLUND I; BENTZEN N
      QUALITY ASSESSMENT AND IMPROVEMENT OF OUTPATIENT ORAL ANTICOAGULANT-THERAPY IN A DANISH COUNTY

      Thrombosis and haemostasis
    21. LUND ED; LASSEN JF; ERIKSEN BS; BRANDSLUND I
      THE EFFECTS OF STORAGE AND MAILING OF SPECIMENS ON THE INTERNATIONAL NORMALIZED RATIO IN MONITORING OF ORAL ANTICOAGULATED PATIENTS

      Thrombosis and haemostasis
    22. KNUDSEN L; CHRISTIANSEN K; POULSEN JM; LASSEN JF; INGERSLEV J
      PROTHROMBIN FRAGMENT 1- OPTIMIZATION OF A KIT ASSAY(2 )

      Thrombosis and haemostasis
    23. KJELDSEN J; LASSEN JF; DEMUCKADELL OBS
      PROTHROMBIN FRAGMENT 1-ANTITHROMBIN-III COMPLEX (TAT) INCREASED IN CROHNS-DISEASE (CD)(2 (F1+2), DEGRADATION PRODUCTS OF FIBRIN (FBDP), ANDTHROMBIN)

      Gastroenterology
    24. LASSEN JF; KJELDSEN J; ANTONSEN S; PETERSEN PH; BRANDSLUND I
      INTERPRETATION OF SERIAL MEASUREMENTS OF INTERNATIONAL NORMALIZED RATIO FOR PROTHROMBIN TIMES IN MONITORING ORAL ANTICOAGULANT-THERAPY

      Clinical chemistry
    25. LASSEN JF; BRANDSLUND I; ANTONSEN S
      INTERNATIONAL NORMALIZED RATIO FOR PROTHROMBIN TIMES IN PATIENTS TAKING ORAL ANTICOAGULANTS - CRITICAL DIFFERENCE AND PROBABILITY OF SIGNIFICANT CHANGE IN CONSECUTIVE MEASUREMENTS

      Clinical chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 15:55:50